Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sofiane Ennifar is active.

Publication


Featured researches published by Sofiane Ennifar.


Pharmacology, Biochemistry and Behavior | 2000

A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats.

Paul R. Pentel; David H. Malin; Sofiane Ennifar; Yoko Hieda; Dan E. Keyler; J.Ronald Lake; Judit R Milstein; Lisa Basham; R.Todd Coy; J.William D Moon; Robert Naso; Ali Fattom

Vaccination of animals to elicit drug-specific antibodies, or the passive transfer of such antibodies from other animals, can reduce the behavioral effects of drugs such as cocaine and heroin. To study the potential application of this approach to treating nicotine dependence, IgG was isolated from rabbits immunized with a nicotine-protein conjugate vaccine. Anesthetized rats received immune IgG containing nicotine-specific antibodies (Nic-IgG) or control-IgG i.v.. Thirty minutes later, rats received nicotine at 0.03 mg/kg i.v., equivalent on an mg/kg basis to the nicotine intake from two cigarettes by a smoker. Compared to control-IgG, Nic-IgG reduced the brain nicotine concentration in a dose-related manner (65% reduction at the highest IgG dose). Pretreatment with Nic-IgG also reduced the distribution to brain of five repeated doses of nicotine (equivalent to the nicotine intake from 10 cigarettes) administered over 80 min. To study blood pressure effects, rats received control-IgG or Nic-IgG 1 day prior to administering nicotine. Nicotine-induced systolic blood pressure increases were attenuated by Nic-IgG in a dose-related manner, and were almost completely blocked by the highest Nic-IgG dose. Pretreatment with Nic-IgG also completely prevented the nicotine-induced stimulation of locomotor activity observed in rats receiving control-IgG. Nic-IgG did not prevent locomotor activation from cocaine, demonstrating its specificity for nicotine. These data demonstrate that the administration of nicotine-specific antibodies can reduce or prevent some of the pharmacokinetic, cardiovascular, and behavioral consequences of nicotine in rats. Effects were observed at nicotine doses and nicotine serum concentrations equal to or exceeding those typically associated with nicotine exposure in cigarette smokers. A potential role for immunization in the treatment of nicotine dependence is suggested.


Life Sciences | 2002

Passive immunization against nicotine attenuates nicotine discrimination

David H. Malin; Candice L Alvarado; Katherine S Woodhouse; Hilary Karp; Evelyn Urdiales; Diana Lay; Phillipa Appleby; William D. Moon; Sofiane Ennifar; Lisa Basham; Ali Fattom

Ten rats were trained in a two lever operant chamber to press different levers after a nicotine injection (0.14 mg/kg s.c.) or a saline injection on an FR10 schedule. The rats were then injected i.p. with either 150 mg nicotine-specific IgG or the same amount of control IgG from non-immunized rabbits. On successive days, they were retested with both levers active after a saline injection, a full training dose of nicotine and a half dose of nicotine (0.07 mg/kg s.c.). After saline injection, both groups pressed the saline lever almost exclusively. After each of the nicotine doses, the immunized rats performed a significantly lower percentage of their lever presses on the nicotine lever than did non-immunized rats. The results suggest that passive immunization can interfere with the stimulus properties of nicotine.


Infection and Immunity | 1998

Antigenic Determinants of Staphylococcus aureus Type 5 and Type 8 Capsular Polysaccharide Vaccines

Ali Fattom; Jawad Sarwar; Lisa Basham; Sofiane Ennifar; Robert Naso


Archive | 1999

Hapten-carrier conjugates for treating and preventing nicotine addiction

Sofiane Ennifar; Ali Fattom; Robert Naso


Pharmacology, Biochemistry and Behavior | 2001

Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome

David H. Malin; J.Ronald Lake; Andy Lin; Michael Saldaña; Laura Balch; M.L.Laredo Irvin; Hishara Chandrasekara; Candice L Alvarado; Yoko Hieda; Dan Keyler; Paul R. Pentel; Sofiane Ennifar; Lisa Basham; Robert Naso; Ali Fattom


Archive | 2006

Method of protecting against staphylococcal infection

Ali Fattom; Jawad Sarwar; Zuzana Kossaczka; Kimberly L. Taylor; Sofiane Ennifar


Nicotine & Tobacco Research | 2010

Passive immunization against nicotine attenuates somatic nicotine withdrawal syndrome in the rat

David H. Malin; William D. Moon; Pilar Goyarzu; Nancy Magallanes; Michelle B. Blair; Melodee R. Alexander; Lauren McDavid; Jason L. Spurgeon; Sofiane Ennifar; Ali Fattom


Archive | 2006

Method for making nicotine hapten

Sofiane Ennifar


Archive | 2006

Methode de protection contre une infection a staphylocoque

Ali Fattom; Zuzana Kossaczka; Kimberly L. Taylor; Sofiane Ennifar; Jawad Sarwar


Archive | 1999

Hapten-bærer-konjugat til behandling og forebyggelse af nicotinafhængighed

Ali Fattom; Robert Naso; Sofiane Ennifar

Collaboration


Dive into the Sofiane Ennifar's collaboration.

Top Co-Authors

Avatar

Ali Fattom

Nabi Biopharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Robert Naso

Nabi Biopharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

David H. Malin

University of Houston–Clear Lake

View shared research outputs
Top Co-Authors

Avatar

Jawad Sarwar

Nabi Biopharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Candice L Alvarado

University of Houston–Clear Lake

View shared research outputs
Top Co-Authors

Avatar

J.Ronald Lake

University of Houston–Clear Lake

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

William D. Moon

University of Houston–Clear Lake

View shared research outputs
Top Co-Authors

Avatar

Yoko Hieda

Hennepin County Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge